Close Get Latest Internet Explorer Get Latest Firefox Get Latest Chrome

Recognition and Awards

Inova serves as first pilot site for PH center accreditation effort

Inova Pulmonary Hypertension Program Site Review ParticipantsInova Fairfax Hospital is the first pilot site in the United States to receive a site visit from the Pulmonary Hypertension Association (PHA). The site visit is part of a nationwide effort to establish a pulmonary hypertension care center accreditation program.  

Inova's Pulmonary Hypertension Program has long been recognized for its excellence in diagnosis, treatment and research for pulmonary hypertension. Co-directed by Steven Nathan, MD, and Oksana Shlobin, MD, the Inova program was visited by reviewers from PHA in late February 2014.

The goal, through accreditation, is to identify the centers of care that provide the highest levels of expertise to effectively treat and manage this rare lung disease.

Dr. Nathan publishes book

Dr. Steven NathanDr. Steven Nathan, medical director of the Inova Advanced Lung Disease and Transplant Program, is internationally recognized for his expertise in serious lung conditions. He is co-editor of a recently published book, Idiopathic Pulmonary Fibrosis: A Comprehensive Clinical Guide.


Christina Kim with award-winning carved pumpkinChristina Kim, research assistant with the Advanced Lung Disease and Transplant Program, took home the 2013 blue ribbon for her sure-to-get-a-smile, lung-inspired creation during Inova Fairfax Hospital's annual pumpkin carving contest.

Dr. Nathan serves as expert resource 

Dr. Steven Nathan recognizedDr. Steven Nathan (right), medical director of Inova's Advanced Lung Disease and Transplant Program, served as a guest lecturer on pulmonary hypertension to medical staff at the University of Texas Medical Branch (UTMB), Galveston. Dr. Nathan is an internationally recognized expert on advanced lung disease and was recognized for his contributions to the field by UTMB's Director of Pulmonary Critical Care and Sleep Medicine, Gulshan Sharma, MD (left).

Tops in one-year outcomes

SRTR logoInova Lung Transplant Program has one of the highest one-year survival rates in the country for lung transplant patients. SRTR, a national scientific registrar for lung transplant outcomes, ranked only three medical facilities nationwide for having surpassed expectations for one-year survival. Inova Fairfax Hospital was ranked at 97 percent. University of California San Francisco Medical Center was ranked at 94 percent and Duke University Hospital came in at 89 percent.

Dr. Steven Nathan, medical director of Inova Advanced Lung Disease and Transplant Program, complimented and thanked all the physicians and clinicians involved in making these outcomes possible. "This is a testament to an outstanding team and teamwork," he said. "All can be proud from the core team to the surgical team, ICU and floor nurses, PAs, PR and all other ancillary services."

Jane Harrison named a "Hero"

Jane Harrison, LCSW, CCTSW

Jane Harrison, LCSW, CCTSW, social work manager for the Advanced Lung Disease and Transplant Program, was recently honored with "Hero" status by her peers in the Society of Transplant Social Workers in recognition of her dedication and commitment to the profession of transplant social work.

Jane is a founding member of the Society and continues to be an active leader. She has served on the Board of Directors as well as By-laws Chair, Abstract Chair and Conference Chair. She is currently Research Chair.

Read Jane's own words on the STSW Web site 

Dr. Nathan on national TV

Dr. Steven Nathan served as an expert resource for pulmonary hypertension on the Health Science Channel.
Watch video arrow

Honors from National Learning Congress

6th Annual National Learning Award

Inova's lung transplant program received a Bronze Award from the National Learning Congress for patient survival while on the waiting list for transplant.

Dr. Nathan is Clinician of the Year

Dr. Nathan-2011 Clinician of the Year AwardDr. Steven Nathan has been named 2011 Clinician of the Year by the Metropolitan DC Chapter of the American Thoracic Society (ATS). He previously was selected as one of the outstanding clinicians for the chapter during the year and is a nominee for the ATS National Clinician of the Year